Why Merit Medical Systems (MMSI) Is Back In The Spotlight

Why Merit Medical Systems Stock Is Back On Investors’ Radar

Merit Medical Systems (MMSI) has drawn fresh attention after reporting second quarter 2026 adjusted EPS of $1.19, which came in 24% above estimates, with revenue topping forecasts by 3.5%.

That earnings beat sits on top of a consistent track record, with the business surpassing projections in each of the past four quarters. This gives investors more concrete data to weigh against the recent share price moves.

Merit Medical Systems’ latest beat comes after a choppy few months, with the share price down 5.0% over 30 days but still up 19.1% over 90 days and delivering a 3-year total shareholder return of 29.5%, which suggests momentum has been building rather than fading.

Spot opportunities beyond Merit Medical Systems by scanning a curated list of healthcare peers that combine earnings strength with solid financial profiles in the list of solid balance sheet and fundamentals (25 results).

The share price has cooled while both analyst targets and one intrinsic value estimate sit meaningfully higher. Where does fair value for Merit Medical Systems really land within that range?

Most Popular Narrative: 16% Undervalued

On the most followed view, Merit Medical Systems is priced below an estimated fair value of $101.45, compared with the latest close at $85.09. This puts the spotlight squarely on how the internal efficiency story holds up.

Merit Medical Systems is still working through multi year efficiency programs that have already lifted non GAAP operating margin to 22.6% in Q2 2026, with management indicating a total expansion target of about 950 basis points versus 2019. If reached, this could continue to support earnings and free cash flow.

See why 1 investors see Merit Medical Systems as 16% undervalued.

Result: Fair Value of $101.45 (UNDERVALUED)

Still, the Merit Medical Systems story can change quickly if WRAPSODY CIE reimbursement stays constrained or if tariff costs continue to pressure profitability.

Find out about the key risks to this Merit Medical Systems narrative.

Next Steps

Mixed signals around Merit Medical Systems can feel messy, so move quickly from headline noise to your own judgment by weighing the 3 key rewards and 1 important warning sign.

Looking for more ideas beyond Merit Medical Systems?

If Merit Medical Systems has sharpened your focus, do not stop there. Broaden your watchlist with fresh ideas that match your risk appetite and return goals.

• Target potential mispricings by scanning a focused group of quality businesses screened on valuation and fundamentals in the 29 high quality undervalued stocks.
• Strengthen your search for resilience by reviewing a 31 resilient stocks with low risk scores that filters for companies with steadier profiles and fewer red flags.
• Get ahead of the crowd by checking a 20 high quality undiscovered gems that highlights lesser known stocks backed by solid underlying numbers.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com